Home › Prostate Cancer › Mississippi › Jackson
Prostate Cancer clinical trials in Jackson, MS
5 studies for Prostate Cancer are looking for participants at sites in and around Jackson (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- University of Mississippi Medical Center, Jackson
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecruitingPhase 3
- University of Mississippi Medical Center, Jackson
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
RecruitingPhase 4
- University of Mississippi Med Ctr, Jackson
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
RecruitingObservational study
- University of Mississippi Medical Center, Jackson
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RecruitingPhase 3
- University of Mississippi Medical Center, Jackson
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
Other studies in Jackson
- Obesity8 studies
- Non-Small Cell Lung Cancer6 studies
- Overweight6 studies
- Lung Cancer6 studies
- Sickle Cell Disease5 studies
- Heart Failure5 studies
- Breast Cancer4 studies
- Burkitt Lymphoma4 studies
- Type 2 Diabetes4 studies
- Schizophrenia4 studies
- Premature Birth4 studies
- Migraine4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.